Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response.
Journal article
Adams A. et al, (2022), Gut
Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy.
Journal article
Selim R. et al, (2022), The lancet. Gastroenterology & hepatology
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease.
Journal article
Wellens J. et al, (2022), Gut, 71, 1919 - 1922
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.
Journal article
Serra EG. et al, (2022), Nature communications, 13
Observational data from the adalimumab post‐marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysis
Journal article
Hart A. et al, (2022), United European Gastroenterology Journal, 10, 485 - 495
Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn’s disease
Journal article
Zhang S. et al, (2022), JCI Insight, 7
Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease.
Journal article
Wellens J. et al, (2022), The lancet. Gastroenterology & hepatology
Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web tool
Journal article
Curtius K. et al, (2022), Gut, 71, 705 - 715
Probing the Microbiome to Predict Response to Biologic Therapy in Inflammatory Bowel Disease-One Step Closer to Precision Medicine?
Journal article
Revés J. et al, (2022), Gastroenterology
Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2
Journal article
Nowak JK. et al, (2022), Journal of Crohn's and Colitis
Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort.
Journal article
Vatn SS. et al, (2022), Clinical and experimental gastroenterology, 15, 5 - 25
Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
Journal article
Chapman TP. et al, (2021), Gastroenterology, 161, 2057 - 2059
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.
Journal article
McGregor CG. et al, (2021), Gut, 70, 2398 - 2400
Systemic Inflammation in Preclinical Ulcerative Colitis.
Journal article
Bergemalm D. et al, (2021), Gastroenterology, 161, 1526 - 1539.e9
SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy.
Journal article
Selim R. et al, (2021), The lancet. Gastroenterology & hepatology
Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 Trials
Journal article
Beelen EMJ. et al, (2021), Clinical Gastroenterology and Hepatology
A Pilot Study on Automatic Three-Dimensional Quantification of Barrett’s Esophagus for Risk Stratification and Therapy Monitoring
Journal article
Ali S. et al, (2021), Gastroenterology, 161, 865 - 878.e8
SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges.
Journal article
Wellens J. et al, (2021), Journal of Crohn's & colitis, 15, 1376 - 1386
Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021.
Journal article
Gupta V. et al, (2021), Journal of Crohn's & colitis, 15, 1211 - 1221